Funded Healthcare Startups
Among the 18 most recent healthcare+AI B2B software funding entries, the largest disclosed round is Judi Health’s $400M (Series F) on 2025-09-25.
Among the 18 most recent healthcare+AI B2B software funding entries, the largest disclosed round is Judi Health’s $400M (Series F) on 2025-09-25. That figure dwarfs the rest of the disclosed amounts in this slice, where most rounds cluster in the low single-digits to tens of millions: examples include OutcomesAI at $10M (2025-10-15), Honey Health at $8M (2025-11-01), Fourier Health at $8M (2025-10-17), and multiple $6M Seed rounds (Ad Scientiam on 2025-11-06 and Vocca on 2025-09-22).
The dates span 2025-09-22 to 2025-11-22, with several closings packed into mid-to-late October (notably 2025-10-17 has three entries: Fourier Health $8M, Altitude $5M, and Synthax $670K). Geographically, the list repeatedly returns to major hubs, especially New York (Arbiter $52M on 2025-11-19; Fourier Health $8M on 2025-10-17), and France (Ad Scientiam $6M on 2025-11-06; Vocca $6M on 2025-09-22). Stage mix is dominated by Seed: 10 of 18 rows list Seed, while 1 is Series F (Judi Health) and 3 are pre-seed (Pype AI, Guideways AI, Case Health AI), with one additional non-standard classification (Ad Scientiam’s “Venture - Series Unknown”) and one undisclosed amount (Case Health AI).
Most recent rounds
18 shownRelated listings
Frequently asked
What’s the largest disclosed round in this healthcare+AI B2B software list, and how extreme is it versus the rest?
Judi Health’s $400M (Series F) on 2025-09-25 is the only disclosed round at the hundreds-of-millions scale in these 18 rows, standing far above the next-largest disclosed amount: Arbiter’s $52M on 2025-11-19. After that, disclosed rounds largely sit in the single-digit-to-low-tens-of-millions band (for example, $10M on 2025-10-15 by OutcomesAI and $8M on 2025-11-01 by Honey Health).
Do the most recent closings cluster in a narrow time window, or are they spread evenly across the full range?
They cluster toward late September through November, with the slice spanning 2025-09-22 to 2025-11-22. A visible concentration occurs on 2025-10-17 with three entries—Fourier Health ($8M), Altitude ($5M), and Synthax ($670K)—all within the same day.
Which cities or geographies show repeated representation in this 18-row view?
New York appears multiple times with Arbiter ($52M, 2025-11-19) and Fourier Health ($8M, 2025-10-17). France also repeats with Ad Scientiam ($6M, 2025-11-06) and Vocca ($6M, 2025-09-22), indicating two separate funded entries from the same country within this date window.
How does stage mix break down across the listed companies, and is any single stage clearly dominant?
Seed dominates this set: 10 of 18 rows are labeled Seed (e.g., Honey Health $8M on 2025-11-01; OutcomesAI $10M on 2025-10-15; Bonsai Health $7M on 2025-09-23). Beyond that, there is 1 Series F (Judi Health $400M on 2025-09-25), 3 pre-seed entries (Pype AI $1M on 2025-11-19; Guideways AI $1M on 2025-11-10; Case Health AI on 2025-09-22 with undisclosed amount), and 1 “Venture - Series Unknown” (Ad Scientiam $6M on 2025-11-06).
Are there notable outliers on the low end, not just the high end?
Yes. Synthax at $670K (Seed) on 2025-10-17 is the smallest disclosed amount among disclosed rows, notably below other sub-$1M entries such as $330K CareLife (Seed) on 2025-10-09 and $400K Do. Sukasu (Seed) on 2025-09-28 are larger than Synthax while still sitting in the sub-$1M range; Case Health AI is an outlier due to its undisclosed amount on 2025-09-22.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.